Cytek Biosciences, Inc.CTKBNASDAQ
LOADING
|||
EV to Sales: Discounted Valuation
Trending lower, below historical average, structural decline.
Left:
||||
Enterprise value to sales ratio
Latest
3.82
↓ 77% below average
Average (5y)
16.34
Historical baseline
Range
High:42.58
Low:3.82
CAGR
-38.3%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | 3.82 | -31.7% |
| 2023 | 5.60 | -16.1% |
| 2022 | 6.67 | -53.0% |
| 2021 | 14.21 | -43.4% |
| 2020 | 25.12 | -41.0% |
| 2019 | 42.58 | - |